Colleen S. Delaney

Hematology | Oncology

1100 Fairview Ave N
Seattle, WA 98109

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 5 publications

Off-the-shelf allogeneic natural killer cells for the treatment of COVID-19.

Off-the-shelf allogeneic natural killer cells for the treatment of COVID-19.

Journal: Molecular therapy. Methods & clinical development

Published: June 05, 2024

Umbilical cord blood: an undervalued and underutilized resource in allogeneic hematopoietic stem cell transplant and novel cell therapy applications.

Umbilical cord blood: an undervalued and underutilized resource in allogeneic hematopoietic stem cell transplant and novel cell therapy applications.

Journal: Current opinion in hematology

Published: September 06, 2022

Maternal microchimerism is prevalent in cord blood in memory T cells and other cell subsets, and persists post-transplant.

Maternal microchimerism is prevalent in cord blood in memory T cells and other cell subsets, and persists post-transplant.

Journal: Oncoimmunology

Published: January 09, 2017

Advances in umbilical cord blood manipulation-from niche to bedside.

Advances in umbilical cord blood manipulation-from niche to bedside.

Journal: Nature reviews. Clinical oncology

Published: December 17, 2014

Cytomegalovirus-specific T cells are primed early after cord blood transplant but fail to control virus in vivo.

Cytomegalovirus-specific T cells are primed early after cord blood transplant but fail to control virus in vivo.

Journal: Blood

Published: February 16, 2013

Showing 1-5 of 5

Last Updated: 09/26/2026